Volume 61, Issue 2 , Pages e5-e8, August 2009
Pregnancy outcomes in psoriasis: Why do we know so little?
Full Text Available
Funding for this work was provided by Astellas Pharma, which had no influence on the content or construction of this paper.
Disclosure: Dr Horn consults with the International Psoriasis Council. Dr Chambers receives grant funding from Amgen, Abbott, Apotex, Bristol-Myers Squibb, Barr Laboratories, Sanofi-Pasteur, Sanofi-Aventis, Sandoz, Kali Laboratories, and TEVA Pharmaceuticals. Dr Menter has served as a consultant, investigator, speaker, or advisory board member for Abbott, Amgen, Astellas, Centocor, Galderma, Genentech, Warner Chilcott, and Wyeth. Dr Kimball has served as a consultant and investigator for Amgen, Centocor, Abbott Laboratories, Neostrata, and Galderma. She is an investigator for Stiefel. She has a fellowship program funded by Centocor.
Reprint requests should be directed to harvardskinstudies@partners.org.
PII: S0190-9622(09)00554-4
doi:10.1016/j.jaad.2009.05.004
© 2009 American Academy of Dermatology, Inc. Published by Elsevier Inc All rights reserved.
Volume 61, Issue 2 , Pages e5-e8, August 2009

